Respiration 2005;72:486–489
(DOI:10.1159/000087672)

C-Reactive Protein in Lymphocytic Pleural Effusions: A Diagnostic Aid in Tuberculous Pleuritis

Garcia-Pachon E. · Soler M.J. · Padilla-Navas I. · Romero V. · Shum C.
Section of Pneumology, Hospital General Universitario, Elche, Spain
email Corresponding Author


 Outline


 goto top of outline Key Words

  • C-reactive protein
  • Lymphocyte
  • Pleural effusion
  • Pleural fluid
  • Thoracocentesis
  • Tuberculosis

 goto top of outline Abstract

Background:C-reactive protein (CRP) pleural fluid levels have been found to be higher in tuberculosis and parapneumonic effusions than in other causes of pleural effusion. Objective:The aim of this study was to analyze whether CRP (a simple and inexpensive test) may be a diagnostic aid for tuberculosis in lymphocytic pleural effusions. Methods:One hundred and forty-four patients with a lymphocytic pleural effusion (more than 50% lymphocytes in the differential white blood cell count) were included. The patients were 93 men (65%) and 51 women (35%), aged 64 ± 18 years (mean ± SD). The diagnoses were as follows: tuberculosis, 20; pleural effusion associated with malignancy, 69; transudates, 38; other benign exudates, 17. Results: The CRP pleural fluid level was higher in tuberculous pleuritis (54 ± 24 mg/l) than in lymphocytic effusions of other origin (21 ± 16 mg/l; p < 0.001). High CRP levels (≥50 mg/l) have a high specificity for tuberculosis (95%), and low levels (<30 mg/l) have a high sensitivity (95%) for excluding disease. Conclusions: CRP pleural fluid level determination is useful in the diagnostic workup of lymphocytic pleural effusions. High CRP levels are very suggestive of tuberculous pleuritis, and low CRP levels make this diagnosis unlikely.

Copyright © 2005 S. Karger AG, Basel


goto top of outline Introduction

In many areas of the world, tuberculosis remains the most common cause of pleural effusion in the absence of demonstrable pulmonary disease [1]. To obtain tubercle bacilli is infrequent in pleural fluid or pleural tissue [2]; consequently, the analysis of the pleural fluid is useful in the diagnosis of tuberculous pleuritis. Several biochemical parameters are of interest in diagnosing tuberculous pleural effusion, especially adenosine deaminase (ADA) [3,4,5]. Since almost all patients with tuberculosis pleural fluid have more than 50% lymphocytes in the pleural white blood cell count [2,6,7,8], the use of ADA has been evaluated in the subgroup of patients with lymphocytic pleural effusions, showing higher diagnostic value [9,10,11,12].

Unfortunately, the ADA test is not available worldwide; most importantly, the test is not accessible in most developing countries where the incidence of tuberculosis is very high. For this reason, alternative tests with lower cost and greater availability are of great interest.

C-reactive protein (CRP) is an acute-phase protein widely used as a marker of inflammation and tissue injury [13]. Its determination is simple, quick and inexpensive. In pleural fluid, CRP levels have been found higher in tuberculosis and parapneumonic effusions than in other causes of pleural effusions [14]. The aim of this study was to analyze whether CRP may be a diagnostic aid for tuberculosis in lymphocytic pleural effusions.

 

goto top of outline Material and Methods

A diagnostic thoracocentesis was performed in 205 consecutive patients. Sixty-one patients were excluded, 41 with nonlymphocytic pleural effusions and 20 with lymphocytic pleural effusions in whom no diagnosis could be obtained. The remaining 144 patients were included in the study. A pleural fluid was considered to be lymphocytic when the differential nucleated cell count revealed more than 50% lymphocytes. The patients were 93 men (65%) and 51 women (35%), aged 64 ± 18 years (mean ± SD).

The final diagnoses of the pleural effusions were established on the basis of well-defined diagnostic criteria usually accepted in the literature and previously detailed by our group [14, 15]. The diagnosis of tuberculous pleural effusion was based on the presence of caseous granulomata in the pleural biopsy and/or positive culture for Mycobacterium tuberculosis in pleural fluid or biopsy material, or positive sputum culture for M. tuberculosis with an exudative pleural effusion. In patients aged 35 years or younger, diagnosis was also made on the basis of a positive skin test and an ADA value >47 U/l, as well as successful treatment with antituberculosis chemotherapy [5].

CRP in pleural fluid was determined by the turbidimetric immunoassay method with a commercial kit (Dimension, Du Pont, Wilmington, Del., USA). The cost of each determination of CRP was lower than USD 1. The normal value of CRP in serum is <10 mg/l.

Statistical analysis was made by a two-tailed unpaired ttest for the differences between CRP pleural fluid levels in tuberculous and nontuberculous pleuritis. A pvalue of <0.05 was considered statistically significant. Sensitivity, specificity, positive likelihood ratio and negative likelihood ratio with 95% confidence intervals of CRP at different cut-off points were calculated.

 

goto top of outline Results

Of the 144 patients included in the study, 20 were diagnosed as having tuberculous pleuritis (14%). Fifteen of them were diagnosed by biopsy (11 patients), culture (1 patient) or both biopsy and culture (3 patients), and the remaining 5 patients on the basis of an ADA level >47 U/l and response to therapy. Diagnoses and CRP levels are detailed in table 1 and in figure 1. On mean, patients with tuberculous pleural effusion had a significantly higher CRP level in pleural fluid. The mean CRP level ± SD in the 20 patients with lymphocytic effusion in whom no diagnosis was obtained was 28 ± 10 mg/l; none of them had a level >50 mg/l.

TAB01

Table 1. Diagnoses and values of C-reactive protein in lymphocytic pleural fluids

FIG01

Fig. 1. Individual values of C-reactive protein in each diagnostic group.

The diagnostic accuracy (sensitivity, specificity, positive and negative likelihood ratios) of CRP in pleural fluid for diagnosing tuberculosis was calculated at different cut-off points (table 2). A CRP level <30 mg/l virtually ruled out the possibility of tuberculosis as the cause of a lymphocytic pleural effusion (sensitivity 95%). A specificity >90% for diagnosing tuberculosis was obtained at a CRP value ≥45 mg/l. When the pleural fluid CRP level was ≥50 mg/l, the specificity was 95%.

TAB02

Table 2. Diagnostic accuracy of C-reactive protein for tuberculous pleuritis at different cut-off values

Since tuberculous pleurisy is always an exudative effusion, data of diagnostic value (specificity) excluding transudates have been analyzed. Results are not significantly different to those obtained in all patients as a whole; for CRP ≥45 mg/l, specificity was 88% (95% CI: 79–94%), and for CRP ≥50 mg/l, it was 93% (95% CI: 85–97%).

 

goto top of outline Discussion

This study shows that the pleural fluid CRP level in lymphocytic pleural effusions has diagnostic value in tuberculous pleuritis. Depending on the CRP level, this diagnosis can be strongly suggested (>50 mg/l) or, on the contrary, can be considered highly unlikely (a CRP pleural fluid level <30 mg/l).

Ideally, the diagnosis of tuberculous pleuritis is made by the demonstration of M. tuberculosis in pleural fluid or in pleural tissue. However, smears of the pleural fluid for mycobacteria are frequently negative [2], and cultures, when positive, take several weeks until results can be obtained [8, 16]. For this reason, in addition to the clinical and radiological characteristics, the cytological and biochemical findings can aid in diagnosing tuberculous pleuritis. At present, several tests are of great interest for diagnosing tuberculous pleural effusion, such as ADA [3,4,5], interferon-=γ [4, 17, 18], lysozyme [4, 19], the polymerase chain reaction [20, 21] or specific antibodies [22]. Lymphocytic predominance in pleural fluid is the rule in tuberculous effusions [2]. This characteristic has been used in order to improve the efficiency of ADA [9,10,11], the most widely used biochemical test for detecting tuberculosis.

However, the tests mentioned above need specific and/or expensive equipment that is not available in most laboratories. From our study, we have determined that measurement of CRP level in pleural fluid can be useful, with the advantage that CRP can be determined in conventional autoanalyzers and is an inexpensive test. In patients with lymphocytic pleural effusion, values of CRP in the pleural fluid >50 mg/l should strongly suggest the possibility of tuberculous pleuritis. On the contrary, low CRP levels (<30 mg/l) virtually ruled out this possibility. Since a biochemical diagnostic test of pleural fluid cannot be considered in a dichotomous view, we have calculated the diagnostic values at different cut-off levels that are more appropriate for clinical purposes.

Previous studies on CRP in pleural fluid concluded that this parameter may differentiate transudates from exudates, but with worse results than those of classical tests [23,24,25]. In one study [23], the authors found that CRP levels were significantly higher in parapneumonic and tuberculous effusions, and our group [14] reported previously that in pleural exudates a CRP <20 mg/l suggests a malignant origin, whereas a level >45 mg/l virtually ruled out this possibility. Very recently, Chierakul et al. [26] studied CRP in 55 patients with tuberculous pleuritis and in 60 patients with malignant pleural effusions. They found that with a cut-off level of CRP ≥30 mg/l, sensitivity was 72 and specificity 93%. However, in the study by Chierakul et al. [26], pleural effusions due to other origins were excluded.

It is well known that other characteristics of the pleural fluid might be useful for diagnosing tuberculous pleurisy. Pleural fluid from patients with tuberculosis rarely contains more than 5% mesothelial cells [6, 7], but the absence of mesothelial cells is not diagnostic of tuberculosis, because in any condition in which the pleural surfaces are extensively involved by an inflammatory process, mesothelial cells are not found in the pleural fluid [1]. A pleural fluid protein level >5 g/dl suggests the diagnosis [1], but is not specific. In the past, it was believed that in tuberculous pleural fluid, the glucose level was reduced and pH was lower than in malignant effusions [27, 28], but now it is known that these data were inaccurate and neither glucose nor pH pleural fluid levels add significant information in cases of tuberculous pleuritis [1, 29, 30]. In conclusion, CRP pleural fluid level determination is a simple and inexpensive test useful in the diagnostic workup of lymphocytic pleural effusions, especially in areas where more sophisticated tests are not available. High CRP levels (>50 mg/l) are very suggestive of tuberculous pleuritis, and low CRP levels make this diagnosis unlikely. Obviously, the exclusive use of this parameter is not enough for diagnosing tuberculous pleurisy, but the CRP pleural fluid level adds significant diagnostic information that should be considered together with all the other epidemiological, clinical, cytological and biochemical data.


 goto top of outline References
  1. Light RW: Tuberculous pleural effusion; in Light RW: Pleural Diseases, ed 4. Philadelphia, Lippincott, 2001, pp 182–195.
  2. Valdes L, Alvarez D, San Jose E, et al: Tuberculous pleurisy: A study of 254 patients. Arch Intern Med 1998;158:2017–2021.
  3. Ocana I, Martinez-Vazquez JM, Segura RM, Fernández de Servilla T, Capdevila JA: Adenosine deaminase in pleural fluids: Test for diagnosis of tuberculous pleural effusion. Chest 1983;103:458–465.
  4. Valdes L, San Jose E, Alvarez D, et al: Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993;103:458–465.
  5. Valdes L, Alvarez D, San Jose E, et al: Value of adenosine deaminase in the diagnosis of tuberculous pleural effusion in young patients in a region of high prevalence of tuberculosis. Thorax 1995;50:600–603.
  6. Yam LT: Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967;66:972–982.
  7. Light RW, Erozan YS, Ball WC: Cells in pleural fluid: Their value in differential diagnosis. Arch Intern Med 1973;132:854–860.
  8. Luzze H, Elliott AM, Joloba ML, et al: Evaluation of suspected tuberculous pleurisy: Clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. Int J Tuberc Lung Dis 2001;5:746–753.
  9. De Oliveira HG, Rossatto ER, Prolla JC: Pleural fluid adenosine deaminase and lymphocyte proportion: Clinical usefulness in the diagnosis of tuberculosis. Cytopathology 1994;5:27–32.
  10. Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ: Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest 1996;109:414–419.
  11. Lee YC, Rogers JT, Rodriguez RM, Miller KD, Light RW: Adenosine deaminase levels in nontuberculous lymphocytic pleural effusions. Chest 2001;120:356–361.
  12. Jimenez Castro D, Diaz Nuevo G, Perez-Rodriguez E, Light RW: Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 2003;21:220–224.
  13. Okamura JM, Miyagi JM, Terada K, Hokama Y: Potential clinical applications of C-reactive protein. J Clin Lab Med 1990;4:231–235.
  14. Garcia-Pachon E, Llorca I: Diagnostic value of C-reactive protein in exudative pleural effusions. Eur J Intern Med 2002;13:246–249.
  15. Garcia-Pachon E, Padilla-Navas I, Dosda MD, Miralles-Llopis MA: Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions. Chest 1997;111:643–647.
  16. Maartens G, Bateman ED: Tuberculous pleural effusions: Increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax 1991;46:96–99.
  17. Ribera E, Ocana I, Martinez-Vazquez JM, Rosell M, Español T, Ruibal A: High level of interferon gamma in tuberculous pleural effusion. Chest 1988;93:308–311.
  18. Villena V, Lopez-Encuentra A, Echave-Sustaeta J, Martin-Escribano P, Ortuno de Solo B, Estenoz Alfaro J: Interferon-gamma in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis. Eur Respir J 1996;9:2635–2639.
  19. Verea Hernando HR, Masa Jimenez JF, Dominguez Juncal L, Perea Garcia-Buela J, Martin Egana MT, Fotan Bueso J: Meaning and diagnostic value of determining the lysozyme level of pleural fluid. Chest 1987;91:342–345.
  20. Querol JM, Minguez J, Garcia-Sanchez E, Farga MA, Gimeno C, Garcia de Lomas J: Rapid diagnosis of pleural tuberculosis by polymerase chain reaction. Am J Respir Crit Care Med 1995;152:1977–1981.
  21. Villena V, Rebollo MJ, Aguado JM, Galan A, Lopez Encuentra A, Palenque E: Polymerase chain reaction for the diagnosis of pleural tuberculosis in immunocompromised and immunocompetent patients. Clin Infect Dis 1998;26:212–214.
  22. Caminero JA, Rodriguez de Castro F, Carrillo T, Lafarga B, Diaz F, Cabrera P: Diagnosis of pleural tuberculosis by detection of specific IgG anti-antigen 60 in serum and pleural fluid. Respiration 1993;60:58–62.
  23. Castano Vidriales JL, Amores Antequera C: Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions. Eur J Med 1992;1:201–207.
  24. Alexandrakis MG, Coulocheri SA, Bouros D, Vlachonicolis IG, Eliopoulos GD: Significance of alpha-2-macroglobulin, alpha-1-acid glycoprotein, and C-reactive protein in pleural effusion differentiation. Respiration 2000;67:30–35.
  25. Yilmaz Turay U, Yildirim Z, Turkoz Y, et al: Use of pleural fluid C-reactive protein in diagnosis of pleural effusions. Respir Med 2000;94:432–435.
  26. Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R: A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004;9:66–69.
  27. Barber LM, Mazzadi L, Deakins DD, et al: Glucose level in pleural fluid as a diagnostic aid. Dis Chest 1957;31:680–681.
  28. Light RW, MacGregor MI, Ball WC, et al: Diagnostic significance of pleural fluid pH and PCO2. Chest 1973;64:591–596.
  29. Chavalittamrong B, Angsusingha K, Tuchinda M, et al: Diagnostic significance of pH, lactic acid dehydrogenase, lactate and glucose in pleural fluid. Respiration 1979;38:112–120.
  30. Good JT, Taryle DA, Maulitz RM, et al: The diagnostic value of pleural fluid pH. Chest 1980;78:55–59.

 goto top of outline Author Contacts

Eduardo Garcia-Pachon, MD
Section of Pneumology, Hospital General Universitario
ES–03203 Elche, Alicante (Spain)
Tel. +34 96 667 90 00, Fax +34 96 667 91 08, E-Mail egpachon@hotmail.com


 goto top of outline Article Information

Received: July 9, 2004
Accepted after revision: October 25, 2004
Number of Print Pages : 4
Number of Figures : 1, Number of Tables : 2, Number of References : 30


 goto top of outline Publication Details

Respiration (International Journal of Thoracic Medicine)

Vol. 72, No. 5, Year 2005 (Cover Date: September-October 2005)

Journal Editor: Bolliger, C.T. (Cape Town)
ISSN: 0025–7931 (print), 1423–0356 (Online)

For additional information: http://www.karger.com/res


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.